Document is current
Any future updates will be listed below
-
Authors
Guo, Wenjing
Li, Jia
Yang, Nuobing
Zhen, Sisi
Zhang, Tingting
Lin, Qingsong
Cao, Yigeng
Cao, Wenbin
Pang, Aiming
Yang, Donglin
Chen, Xin
Zhang, Rongli
Wei, Jialin
Ma, Qiaoling
Zhai, Weihua
He, Yi
Zheng, Yizhou
Jiang, Erlie
Han, Mingzhe
Feng, Sizhou
-
Funding
Funding for this research was provided by:
Fundamental Research Funds for the Central Universities, Peking Union Medical College (3332024077)
Tianjin Municipal Science and Technology Commission Grant (25ZXRKSY00040)
National Key R&D Program of China (2024YFC2510500)
National Natural Sciences Foundation of China (82470208)
Research Fund for Clinical Application of Amphotericin B Antifungal Agents (KC2024-JX-0092-1)
- License Information
-
More Information
Article History
Received: 10 March 2026
Accepted: 18 May 2026
First Online: 27 May 2026
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki. Ethical approval was obtained from the Ethics Committee of the Blood Diseases Hospital, Chinese Academy of Medical Sciences. Lot number: IIT2021011-EC-1. All procedures involving human participants were performed in accordance with the ethical standards of the institutional research committee. Written informed consent was obtained from all participants or their legal guardians before sample collection.
: Not applicable.
: The authors declare no competing interests.
